Risk Minimisation and Communication: Pharmacoepidemiological Approaches and Case Studies for Designing and Evaluating Interventions for the Safe Use of Medicines
9:00 AM - 12:30 PM ET
SC-19 - Risk Minimisation and Communication: Pharmacoepidemiological Approaches and Case Studies for Designing and Evaluating Interventions for the Safe Use of Medicines
Location: Room 201
Presenting Author: Priya Bahri, PhD – European Medicines Agency (EMA)
Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Co-Author: Hector S. Izurieta, MD, PhD – Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, White Oak, MD